Want help reviewing this study?
Study ID: NCT05384392. We help you review the study, but cannot decide medical eligibility.
RecruitingNCT05384392
Biomarkers Predictive of Thymic Evolution and Therapeutic Response at 2 Years in Patients With a First Psychotic Episode
A short description of this study’s research objective has not yet been verified.
Study assessmentsAges 15–30FranceSchizophrenia
Understand this study
Who could participate?
Listed age limits: 15 years to 30 years.
- Listed locations
- Angers, France · Brest, France and 3 more locationsSee all locations and recruitment
- Activities
- Study assessments
- Compensation
- Payment and expense reimbursement have not been verified.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: March 27, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 217
- Sponsor
- University Hospital, Brest
- Sponsor type
- Hospital / academic medical center
- Study type
- Biological
- Intervention type
- BIOLOGICAL, OTHER
- Study phase
- Not clearly listed
- Locations
- France
- Age range
- From 15 Years to 30 Years
- Official registry ID
- NCT05384392
- Official title
- Biomarkers Predictive of Thymic Evolution and Therapeutic Response at 2 Years in Patients With a First Psychotic Episode
Recruitment & locations
RecruitingAngers · Brest · Nantes
2 more locations
- Rennes
- Tours
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is University Hospital, Brest, a hospital or academic medical center.
Who can participate?
Listed age limits: 15 years to 30 years.
Is this study still recruiting?
The registry lists this study as recruiting.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
RecruitingNCT06634641
Clozapine-related Immunodeficiency in Parkinsons Disease
This study is recruiting. It focuses on schizophrenia and currently lists participation information in France.
RecruitingNCT06613334
Voice-Based Biomarkers: A Novel Approach to Monitoring and Predicting Schizophrenia Relapses
This study is recruiting. It focuses on schizophrenia and currently lists participation information in France.
RecruitingNCT05511363
KarXT for Schizophrenia
The registry lists this study as recruiting. Study locations are listed in the United States, in France, in the United Kingdom, ... Confirm recruitment at each site. It is testing KarXT for Schizophrenia.